Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidotimod in Children With Recurrent Respiratory Tract Infections
NCT04322669Phase 4Completed
- Sponsor
- Almirall
- Start
- Aug 2021
- Primary completion
- Nov 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pidotimod in Recurrent respiratory tract infections (RRTIs), sponsored by Almirall. Started Aug 2021; status: completed.
02
Drugs
pidotimod
03
Conditions
Recurrent respiratory tract infections (RRTIs)
Beyond the preview
Go deeper on NCT04322669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322669.